MedPath

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

Recruiting
Conditions
Breast Cancer
Interventions
Other: Breast cancer
Registration Number
NCT06220630
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Brief Summary

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:

* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.

Researchers will investigate the features, survival associated factors and other relevant factors of this population.

Detailed Description

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:

* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.

Researchers will investigate the features, survival associated factors and other relevant factors of this population.

The collected variables included: survival time, survival status, year of diagnosis, age, stage, molecular subtype statuses, histology, grade, and surgery, radiotherapy and systemic therapies utilization.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
1200
Inclusion Criteria
  • Biological sex is male;
  • Microscopically diagnosed as primary breast cancer.
Exclusion Criteria
  • Presence of skin-origin malignancy on the breast.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ChineseBreast cancerAbout 1,200 Chinese male breast cancer cases are anticipated to collected retrospectively. The clinicopathological characteristics, treatment and survival information are retrospectively collected.
Primary Outcome Measures
NameTimeMethod
Overall survivalFrom the time of diagnosis to August 1, 2024 (anticipated).

The duration between the date of the first pathologic diagnosis and death from any cause or last follow-up.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

First affiliated hospital of Sun Yat-sen university

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath